Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmaceutical impurity identification: a case study using a multidisciplinary approach.

Karen M Alsante1, Peter Boutros, Michel A Couturier

  • 1Analytical Research & Development Department, Pharmaceutical Sciences, Pfizer Global Research & Development, Pfizer Inc., Groton, Connecticut 06340, USA.

Journal of Pharmaceutical Sciences
|August 6, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostaglandin E<sub>2</sub>-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarcinoma.

Signal transduction and targeted therapy·2026
Same author

Cross-platform deep learning enables automated cytomorphologic subtyping of acute leukemia from bone marrow smears.

Virchows Archiv : an international journal of pathology·2026
Same author

PIEZO1 enhances pancreatic cancer neurotropism.

Cancer cell international·2026
Same author

The Limb-bud and Heart (LBH) promotes renal fibrosis through endoplasmic reticulum stress-induced pyroptosis and partial epithelial-mesenchymal transition in renal tubular epithelial cells.

Cellular signalling·2026
Same author

EvoMDT: a self-evolving multi-agent system for structured clinical decision-making in multi-cancer.

NPJ digital medicine·2026
Same author

Alternative Splicing of Secretin Receptor (SCTR) and Its Low Expression Drive the Occurrence of Pancreatic Ductal Adenocarcinoma.

Pancreas·2025
Same journal

Green, renewable, or low-carbon? A framework for informed solvent selection in pharmaceutical sciences.

Journal of pharmaceutical sciences·2026
Same journal

Theranostic potential of ramucirumab functionalized magnetoliposomes for targeted delivery of sorafenib and MRI.

Journal of pharmaceutical sciences·2026
Same journal

Intranasal mucoadhesive chitosan microspheres of ranolazine: Formulation, design, and pharmacokinetic evaluation.

Journal of pharmaceutical sciences·2026
Same journal

Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needs.

Journal of pharmaceutical sciences·2026
Same journal

A mathematical framework for predicting tablet weight variability from blend particle size distribution and tooling geometry.

Journal of pharmaceutical sciences·2026
Same journal

Recrystallization can stop nitrosamine formation in ranitidine hydrochloride.

Journal of pharmaceutical sciences·2026
See all related articles
This summary is machine-generated.

A multidisciplinary strategy using LC-MS, LC-NMR, and preparative HPLC effectively identifies pharmaceutical impurities. Degradation studies provide crucial structural insights, even for unstable compounds.

Area of Science:

  • Analytical Chemistry
  • Pharmaceutical Analysis

Background:

  • Identifying pharmaceutical impurities is critical for drug safety and regulatory compliance.
  • Established analytical techniques may not always be sufficient for complex impurity structures.

Purpose of the Study:

  • To present a systematic, multidisciplinary approach for identifying unknown pharmaceutical impurities.
  • To demonstrate the application of this strategy using a case study of an impurity in a specific active pharmaceutical ingredient.

Main Methods:

  • Liquid chromatography-mass spectrometry (LC-MS) for initial analysis.
  • Liquid chromatography-nuclear magnetic resonance (LC-NMR) for structural elucidation.
  • Preparative high-performance liquid chromatography (HPLC) and solid-phase extraction for impurity isolation.

Related Experiment Videos

  • Conventional NMR and degradation studies for comprehensive characterization.

    • Main Results:

    • The integrated approach successfully identified a complex impurity in the active pharmaceutical ingredient 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[4-(1-hydroxy-1-methyl-ethyl)-furan-2-sulphonylurea.
    • The impurity's instability under acidic conditions was leveraged to gain additional structural information through a degradation study.
    • Complementary data from multiple analytical techniques enabled definitive structure elucidation.

    Conclusions:

    • A multidisciplinary strategy combining chromatography, mass spectrometry, NMR, and degradation studies is highly effective for pharmaceutical impurity identification.
    • Degradation studies can provide valuable structural insights, particularly for impurities exhibiting instability.
    • This systematic approach ensures comprehensive characterization and verification of pharmaceutical impurities.